Virtual Event
-
Drug Development Considerations for the Prevention of Healthcare Associated Infections
Virtual Event
Drug Development Considerations for the Prevention of Healthcare Associated Infections
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures, speaker slides, workshop recording, and transcript—will be posted here shortly before and/or after the completion of the workshop. The current state of development of pathogen-directed